Intas Pharmaceuticals Limited Quinine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Quinine Export Records India — #3 Exporter, 10 Shipments, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Quinine

India Pharmaceutical Trade Intelligence

$19.3M236 Suppliers93 CountriesHS 30049099

ExportsIndia → UNITED KINGDOM26.0%India → CAMEROON12.7%

ImportsUNITED KINGDOM → India$382.1K UNITED STATES → India$2.8K

#1 Supplier: STRIDES PHARMA

Intas Pharmaceuticals Limited — Quinine Exporter #3 | $500.0K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Quinine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Quinine · $500.0K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Quinine with $500.0K in export value and 10 verified shipments. Intas Pharmaceuticals Limited holds a 2.6% market share in Quinine exports across 4 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Quinine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Quinine export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Quinine?

Country	Value	Shipments	Share
CENTRAL AFRICAN REPULIC	$123.8K	4	34.0%
SOUTH SUDAN	$91.3K	2	25.1%
SUDAN	$77.4K	2	21.3%
CENTRAL AFRICAN REPUBLIC	$40.8K	1	11.2%

Who Are the Top Buyers of Quinine from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
UNICEF SOUTH SUDAN	SOUTH SUDAN	$91.3K	2
UNICEF BANGUI	CENTRAL AFRICAN REPUBLIC	$90.8K	2
PROJET D'APPUI ET DE RENFORCEMENT	CENTRAL AFRICAN REPULIC	$73.8K	3
UNICEF SOUTH SUDAN TOTO CHAN	SUDAN	$50.0K	1
UNICEF SUPPLY DIVISION COPENHAGEN	DENMARK	$30.5K	1
UNICEF SOUTH SUDAN TOTO CHAN COMPOUND POBOX ADDISABABA	SUDAN	$27.4K	1

Intas Pharmaceuticals Limited supplies Quinine to 6 buyers globally. The largest buyer is UNICEF SOUTH SUDAN (SOUTH SUDAN), followed by UNICEF BANGUI (CENTRAL AFRICAN REPUBLIC) and PROJET D'APPUI ET DE RENFORCEMENT (CENTRAL AFRICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Quinine Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJE	$145.6K	5
PHAR DRUG & MED :-Quinine DiHCL 600mg/2ml InjS1560600 Quinine DihydrochlorideInjection 600mg/2 ml For IM or Slow IV	$50.0K	1
PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJECTION 600MG/2ML FOR IM OR SLOW IV INFUSION(EACH ML CONT.QUININE DIHCL 300MG[1X10	$50.0K	1
PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJECTION 600MG/2ML FOR IM OR SLOW IV INFUSION (EACH ML CONT.QUININE DIHCL 300MG) [1	$50.0K	1
PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJECTION 600MG/2ML FOR IM OR SLOW IV INFUSIONEACH ML CONT.QUININE DIHCL 300MG[1X10	$40.8K	1
PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJECTION 600MG/2ML FOR IM OR SLOW IV INFUSION EACH ML CONT.QUININE DIHCL 300MG [1	$27.4K	1

Intas Pharmaceuticals Limited exports 6 distinct Quinine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PH.DRU.&MED:QUININE DIHYDROCHLORIDE INJE with 5 shipments worth $145.6K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Quinine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	NUCARE LABS LLP	$565.9K	38	2	$14.9K
7	SCOTT EDIL PHARMACIA LIMITED	$548.3K	11	3	$49.8K
3	INTAS PHARMACEUTICALS LIMITED ★	$500.0K	10	4	$50.0K
9	KAMLA LIFESCIENCES LIMITED	$323.5K	7	2	$46.2K
8	REDWING PHARMA PRIVATE LIMITED	$300.0K	6	1	$50.0K

Intas Pharmaceuticals Limited ranks #3 among 236 Indian Quinine exporters. Average shipment value of $50.0K compared to the market average of $35.6K. The closest competitors by value are NUCARE LABS LLP and SCOTT EDIL PHARMACIA LIMITED.

Which Indian Ports Ship Quinine Exports?

Port	Shipments	% Share
SAHAR AIR	287	19.0%
SAHAR AIR CARGO ACC (INBOM4)	286	18.9%
NHAVA SHEVA SEA (INNSA1)	167	11.1%
JNPT/ NHAVA SHEVA SEA	74	4.9%
JNPT	65	4.3%
AHEMDABAD ICD	55	3.6%
Bombay Air	50	3.3%
NHAVA SHEVA	35	2.3%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Quinine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Quinine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 10 individual customs records matching Intas Pharmaceuticals Limited exporting Quinine, covering 6 formulations to 5 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 468+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Quinine

Quinine

Intas Pharmaceuticals Limited — Quinine Exporter Profile

Intas Pharmaceuticals Limited — Quinine Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Quinine?

Who Are the Top Buyers of Quinine from Intas Pharmaceuticals Limited?

What Is India's Total Quinine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Quinine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Quinine Exporters?

What Quinine Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Quinine Exporters?

Which Indian Ports Ship Quinine Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Quinine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Quinine Export Data from Intas Pharmaceuticals Limited

Quinine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source